NEW STATEWIDE CHALLENGE
There is a NEW challenge for EVERY STATE in the U.S.A.
from now until December 31, 2018!
CURE HHT PATIENT & PHYSICIAN CONFERENCE
October 20-21, 2018
Ann Arbor, MI
EARLY BIRD REGISTRATION RATES THROUGH 9/30/18
Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu Syndrome, is an inherited disease that leads to malformed blood vessels in multiple organs of the body and typically begins with nosebleeds during childhood. HHT can result in serious health problems if not promptly diagnosed and treated. Our mission is to find a cure for HHT while saving the lives and improving the well-being of individuals and families affected by HHT.